161 related articles for article (PubMed ID: 30991713)
1. Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers.
Saha SK; Kim KE; Islam SMR; Cho SG; Gil M
J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30991713
[TBL] [Abstract][Full Text] [Related]
2. A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (
Karim MA; Samad A; Adhikari UK; Kader MA; Kabir MM; Islam MA; Hasan MN
Biomedicines; 2020 Jan; 8(2):. PubMed ID: 31973134
[TBL] [Abstract][Full Text] [Related]
3. Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.
Scully OJ; Yu Y; Salim A; Thike AA; Yip GW; Baeg GH; Tan PH; Matsumoto K; Bay BH
Exp Biol Med (Maywood); 2015 Jul; 240(7):846-53. PubMed ID: 25573962
[TBL] [Abstract][Full Text] [Related]
4. High Expression of
Saha SK; Biswas PK; Gil M; Cho SG
J Clin Med; 2019 Oct; 8(11):. PubMed ID: 31652813
[TBL] [Abstract][Full Text] [Related]
5. Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis.
Zhang X; Zhang F; Guo L; Wang Y; Zhang P; Wang R; Zhang N; Chen R
Mol Cell Proteomics; 2013 Nov; 12(11):3199-209. PubMed ID: 23924515
[TBL] [Abstract][Full Text] [Related]
6. C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I.
Kim K; Kim MJ; Kim KH; Ahn SA; Kim JH; Cho JY; Yeo SG
Exp Ther Med; 2017 May; 13(5):2493-2500. PubMed ID: 28565870
[TBL] [Abstract][Full Text] [Related]
7. Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers.
Matsumoto K; Bay BH
Curr Med Chem; 2021; 28(25):5048-5065. PubMed ID: 33390103
[TBL] [Abstract][Full Text] [Related]
8. C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways.
Scully OJ; Shyamasundar S; Matsumoto K; Dheen ST; Yip GW; Bay BH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674861
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death.
McGee AM; Douglas DL; Liang Y; Hyder SM; Baines CP
Cell Cycle; 2011 Dec; 10(23):4119-27. PubMed ID: 22101277
[TBL] [Abstract][Full Text] [Related]
10. The Mitochondrial Protein C1QBP Promotes Hepatocellular Carcinoma Progression by Enhancing Cell Survival, Migration and Invasion.
Hou G; Lu Z; Wang Z; Yang X
J Cancer; 2022; 13(8):2477-2489. PubMed ID: 35711850
[No Abstract] [Full Text] [Related]
11. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
Shi H; Fang W; Liu M; Fu D
Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
[TBL] [Abstract][Full Text] [Related]
12. [Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
Shen X; Han B; Shen Y; Yang J; Ren T; Sha G; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):616-20. PubMed ID: 25354864
[TBL] [Abstract][Full Text] [Related]
13. Complement component 1q subcomponent binding protein in the brain of the rat.
Barna J; Dimén D; Puska G; Kovács D; Csikós V; Oláh S; Udvari EB; Pál G; Dobolyi Á
Sci Rep; 2019 Mar; 9(1):4597. PubMed ID: 30872665
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract][Full Text] [Related]
15. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
[TBL] [Abstract][Full Text] [Related]
16. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
17. Systematic Analysis of Gene Expression Alteration and Co-Expression Network of Eukaryotic Initiation Factor 4A-3 in Cancer.
Lin Y; Zhang J; Cai J; Liang R; Chen G; Qin G; Han X; Yuan C; Liu Z; Li Y; Zou D; Mao Y
J Cancer; 2018; 9(24):4568-4577. PubMed ID: 30588240
[No Abstract] [Full Text] [Related]
18. Meta-analysis of gene expression alterations and clinical significance of the HECT domain-containing ubiquitin ligase HUWE1 in cancer.
Su C; Wang T; Zhao J; Cheng J; Hou J
Oncol Lett; 2019 Sep; 18(3):2292-2303. PubMed ID: 31404287
[TBL] [Abstract][Full Text] [Related]
19. The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.
Li Y; Huang J; Sun J; Xiang S; Yang D; Ying X; Lu M; Li H; Ren G
Oncotarget; 2017 Jan; 8(3):4501-4519. PubMed ID: 27966459
[TBL] [Abstract][Full Text] [Related]
20. Multi-Omics Analysis of
Seok J; Gil M; Dayem AA; Saha SK; Cho SG
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
